Evogene Ltd. (EVGN)
NASDAQ: EVGN
· Real-Time Price · USD
1.29
-0.07 (-5.15%)
At close: Jun 26, 2025, 3:59 PM
1.32
2.33%
After-hours: Jun 26, 2025, 07:57 PM EDT
-5.15% (1D)
| Bid | 1.26 |
| Market Cap | 8.61M |
| Revenue (ttm) | 8.51M |
| Net Income (ttm) | -16.48M |
| EPS (ttm) | -2.51 |
| PE Ratio (ttm) | -0.51 |
| Forward PE | -0.92 |
| Analyst | Buy |
| Ask | 1.34 |
| Volume | 145,589 |
| Avg. Volume (20D) | 2,156,261 |
| Open | 1.37 |
| Previous Close | 1.36 |
| Day's Range | 1.27 - 1.37 |
| 52-Week Range | 0.95 - 7.20 |
| Beta | 1.36 |
About EVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+30.93%
Evogene shares are trading higher after the compan...
Unlock content with
Pro Subscription
8 months ago
+19.92%
Evogene shares are trading higher after the company announced its subsidiary received a grant from the Israel Innovation Authority to advance its program to develop a technology for the delivery of Ag-biologicals to agriculture.
